Dr. Rengan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1959 NE Pacific St
Seattle, WA 98195Phone+1 206-598-4100
Summary
- Dr. Rengan is a board-certified radiation oncologist who specializes in radiation treatment for lung, melanoma, and prostate cancer.
Dr. Rengan was previously the Chief of Thoracic Service and Associate Director of Clinical Operations for the Department of Radiation Oncology at the University of Pennsylvania, where he worked extensively with proton therapy. He completed his residency in radiation oncology at Memorial Sloan-Kettering Cancer Center in 2006 and earned his medical degree and Ph.D. in biological chemistry from University of Michigan Medical School and Rackham School of Graduate Studies in 2001.
Dr. Rengan’s philosophy of “patients come first” fits well with his areas of research, which involve the development of clinical and translational (bench-to-bedside) initiatives designed to improve clinical outcomes in cancer. His research interests also include understanding the biology of cancer in order to make radiation treatment more effective and using radiation as a tool to stimulate the immune system to target the cancer.
Education & Training
- Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2002 - 2006
- St Mary's Hospital and Medical CenterInternship, Internal Medicine, 2001 - 2002
- University of Michigan Medical SchoolClass of 2001
Certifications & Licensure
- WA State Medical License 2013 - 2025
- PA State Medical License 2006 - 2024
- CA State Medical License 2021 - 2023
- NY State Medical License 2002 - 2015
- NJ State Medical License 2006 - 2013
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery Start of enrollment: 2007 Jun 01
- Flaxseed Supplement in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Undergoing Chemotherapy and Radiation Therapy Start of enrollment: 2007 Dec 01
- Proton Beam Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery Start of enrollment: 2010 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 1760 citationsRadiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancerChristina Twyman-Saint Victor, Andrew J. Rech, Amit Maity, Ramesh Rengan, Kristen E. Pauken
Nature. 2015-04-16 - 29 citationsProton beam therapy and immunotherapy: an emerging partnership for immune activation in non-small cell lung cancerHoward J. Lee, Jing Zeng, Ramesh Rengan
Translational Lung Cancer Research. 2018-04-01 - 3 citationsPhase II Trial of Flaxseed to Prevent Acute Complications After Chemoradiation for Lung Cancer.Tristan L. Lim, Ralph A. Pietrofesa, Evguenia Arguiri, Constantinos Koumenis, Steven J. Feigenberg
Journal of Alternative and Complementary Medicine. 2021-06-23
Press Mentions
- Clinical Oncology Findings from Seattle Cancer Care Alliance (SCCA) Clinicians to Be Featured at the 2021 ASCO Annual MeetingJune 3rd, 2021
- Low-Dose Radiotherapy for Lung Inflammation in Severe COVID-19November 5th, 2020
- Can Low-Dose Radiotherapy Treat COVID-19-Related Pneumonia?November 3rd, 2020
- Join now to see all
Committees
- Committee member, National Cancer Institute’s Radiation and Immune Modulation Working Group
- Associate Senior Editor, Journal “Advances in Radiation Oncology."
External Links
- SCCA Proton Therapy Centerhttp://www.sccaprotontherapy.com
- UW Medicinehttp://www.uwmedicine.org
- Fred Hutchinson Cancer Research Centerhttp://www.fredhutch.org
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: